21344-24-1 Usage
Uses
Used in Pharmaceutical Development:
5-bromothieno[2,3-b]pyridine is used as a key intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs with therapeutic properties.
Used in Agrochemical Production:
5-bromothieno[2,3-b]pyridine is utilized as an intermediate in the production of agrochemicals, where its unique structure can enhance the effectiveness of these chemicals in agricultural applications.
Used in Organic Chemistry Research:
5-bromothieno[2,3-b]pyridine is employed as a building block in organic chemistry for the synthesis of new chemical entities, exploring its reactivity and potential applications in creating novel compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5-bromothieno[2,3-b]pyridine is used as a structural component in the design and synthesis of molecules with potential biological activity, aiming to discover new therapeutic agents.
Overall, the diverse range of applications and potential biological activity of 5-bromothieno[2,3-b]pyridine make it a valuable compound in both chemical and pharmaceutical research, driving innovation and development in these fields.
Check Digit Verification of cas no
The CAS Registry Mumber 21344-24-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,3,4 and 4 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 21344-24:
(7*2)+(6*1)+(5*3)+(4*4)+(3*4)+(2*2)+(1*4)=71
71 % 10 = 1
So 21344-24-1 is a valid CAS Registry Number.
21344-24-1Relevant academic research and scientific papers
SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES
-
Paragraph 0760, (2017/11/01)
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows: wherein U1, U2, U3, R1, R2, Z, and W are defined herein.
BIARYL ACETAMIDE COMPOUNDS AND METHODS OF USE THEREOF
-
Paragraph 000171, (2015/03/16)
Biaryl acetamide compounds and compositions and their methods of use are provided for modulating the activity of class III receptor tyrosine kinases and for the treatment, prevention or amelioration of one or more symptoms of disease of disorder mediated by class III receptor tyrosine kinases.
PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS
-
Page/Page column 284, (2010/11/03)
The present invention provides methods for inhibiting mTOR using pyrazolo[1,5-a]pyrimidine compounds and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with mTOR using such compounds.
SPIROCYCLIC AZAADAMANTANE DERIVATIVES AND METHODS OF USE
-
Page/Page column 25, (2008/12/06)
The invention relates to compounds that are spirocyclic azaadamantane derivatives derivatives, particularly spirocyclic azaadamantanyl ether or amine derivatives, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes.
